Back to search
Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis trials you may qualify forThe goal of this clinical trial is to learn whether pemafibrate can help prevent worsening of intracranial arterial stenosis (ICAS) in patients who have symptom…
IRIS-sICAS is a multicenter, randomized, double-blind, placebo-controlled clinical trialis a multicenter, randomized, double-blind, placebo-controlled clinical…
Background: Intracranial atherosclerotic stenosis (ICAS) is a major etiology of stroke worldwide, especially in East and South Asia, accounting for up to 50% o…
The primary goal of the trial is to investigate whether the experimental arms (receiving the Proprotein Convertase Subtilisin-Kexin Type 9 \[PCSK9\] inhibitor E…
The primary objective of the study will be to determine whether remote limb ischemic conditioning (RLIC) compared with sham RLIC (placebo) treatment reduces the…